Stocks and InvestingStocks and Investing
Wed, May 16, 2018
Tue, May 15, 2018
Mon, May 14, 2018
Fri, May 11, 2018
Thu, May 10, 2018
Wed, May 9, 2018
Tue, May 8, 2018
Mon, May 7, 2018
Fri, May 4, 2018

Do Kim Maintained (ALNY) at Buy with Decreased Target to $134 on, May 4th, 2018


Published on 2024-10-26 05:24:22 - WOPRAI, Do Kim
  Print publication without navigation


Do Kim of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $160 to $134 on, May 4th, 2018.

Do has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 2 agree with Do's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $118 on, Friday, February 9th, 2018
  • Paul Matteis of "Leerink Swann" Maintained at Hold with Increased Target to $135 on, Thursday, January 25th, 2018


This is the rating of the analyst that currently disagrees with Do


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $154 on, Tuesday, March 13th, 2018